Validation of a Dermatology-Specific Treatment Satisfaction Instrument

University of Southern California1 site in 1 country120 target enrollmentNovember 13, 2021

ConditionsPsoriasis

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Psoriasis
Sponsor: University of Southern California
Enrollment: 120
Locations: 1
Primary Endpoint: Validity and reliability of a dermatology-specific treatment satisfaction instrument in patients with psoriasis
Status: Active, not recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The primary objective of this study is to validate a dermatology-specific questionnaire that assesses patient satisfaction with their treatments across various inflammatory dermatology diseases.

Registry

clinicaltrials.gov

Start Date

November 13, 2021

End Date

December 2023

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University of Southern California

Responsible Party

Principal Investigator

April Armstrong

Professor

University of Southern California

Eligibility Criteria

Inclusion Criteria

•Adult (≥ 18 years)
•Psoriasis patients undergoing some form of treatment

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Validity and reliability of a dermatology-specific treatment satisfaction instrument in patients with psoriasis

Time Frame: 8 months

For this survey study, the investigators will gather descriptive statistics for each item in the questionnaire. The investigators will also measure the following psychometric properties: measurement error, reliability and construct validity, as measured by convergent and known-groups validity